Breast Cancer Screening Market Scope And Analysis

Report Code : TIPRE00009796
Category : Medical Device

Status : Published
No. of Pages : 156

Buy Now

Breast Cancer Screening Market Analysis, Trends, and Scope 2020 to 2027

Buy Now

Breast Cancer Screening Market Report Scope

Report Attribute	Details
Market size in 2019	US$ 4.64 Billion
Market Size by 2027	US$ 6.21 Billion
Global CAGR (2019 - 2027)	4.8%
Historical Data	2017-2018
Forecast period	2020-2027
Segments Covered	By Test Type Blood Marker tests Imaging Test Genetic Test Immunohistochemistry Test By End User Hospitals Diagnostic Centers Cancer Institutes Research Laboratories
Regions and Countries Covered	North America US Canada Mexico Europe UK Germany France Russia Italy Rest of Europe Asia-Pacific China India Japan Australia Rest of Asia-Pacific South and Central America Brazil Argentina Rest of South and Central America Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	Koninklijke Philips N V HOLOGIC INC BD MYRIAD GENETICS INC SIEMENS HEALTHCARE GMBH Exact Sciences Corporation ONCOCYTE CORPORATION POC MEDICAL SYSTEMS Danaher

Breast Cancer Screening Market – By Product Type

Blood Marker Test
Imaging Test
Genetic Test
Immunohistochemistry Test

Breast Cancer Screening Market – By Application

Diagnostic Centers
Hospitals
Research Laboratories
Cancer Institutes

Breast Cancer Screening – By Geography

North America
- US
- Canada
- Mexico
Europe
- France
- Germany
- Italy
- UK
- Spain
- Rest of Europe
Asia Pacific
- China
- India
- South Korea
- Japan
- Australia
- Rest of Asia Pacific
Middle East and Africa
- South Africa
- Saudi Arabia
- UAE
- Rest of Middle East and Africa
South America
- Brazil
- Argentina
- Rest of South America

Company Profiles

General Electric Company
Siemens Healthineers AG
Exact Sciences Corporation
Koninklijke Philips N.V.
Hologic, Inc.
BD
Myriad Genetics, Inc.
Oncocyte Corporation
Danaher
POC Medical Systems